Stay updated on DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial

Sign up to get notified when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The clinical-trial record for DONATE is now displayed, describing a completed observational study of dapagliflozin safety in people with type 2 diabetes in China, along with its eligibility criteria, locations, outcomes, and data-sharing details.
    Difference
    70%
    Check dated 2026-11-07T23:37:59.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s displayed ClinicalTrials.gov revision changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T17:34:11.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces updates and a transition from the term “Artificial Intelligence” to “Super Intelligence.” It appears above the page’s 403 error response.
    Difference
    1%
    Check dated 2026-10-24T20:25:28.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T22:10:27.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:08:34.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page instead of the study details, indicating access to the record is blocked.
    Difference
    16%
    Check dated 2026-09-19T20:54:30.000Z thumbnail image

Stay in the know with updates to DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.